Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-15-038058

Director acquired 700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Griggs Jonathan Director 2015-04-28 Option exercise +700 $6.69 $4,683 6,645 D
Derivatives
Griggs Jonathan Director 2015-04-28 Option exercise · Options −700 0 D
Loading xslF345X03/doc4.xml…